These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20547751)

  • 1. Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.
    Deisenroth C; Thorner AR; Enomoto T; Perou CM; Zhang Y
    Mol Cell Biol; 2010 Aug; 30(16):3981-93. PubMed ID: 20547751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective effects of a fiber chimeric conditionally replicative adenovirus armed with hep27 gene on renal cancer cell.
    Fang L; Cheng Q; Liu W; Zhang J; Ge Y; Zhang Q; Li L; Liu J; Zheng J
    Cancer Biol Ther; 2016 Jun; 17(6):664-73. PubMed ID: 27195521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
    Brekman A; Singh KE; Polotskaia A; Kundu N; Bargonetti J
    Breast Cancer Res; 2011 Jan; 13(1):R3. PubMed ID: 21223569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation.
    Xia M; Knezevic D; Tovar C; Huang B; Heimbrook DC; Vassilev LT
    Cell Cycle; 2008 Jun; 7(11):1604-12. PubMed ID: 18520179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells.
    Raza S; Ohm JE; Dhasarathy A; Schommer J; Roche C; Hammer KD; Ghribi O
    Mol Cell Biochem; 2015 Dec; 410(1-2):187-95. PubMed ID: 26350565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
    Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
    Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
    Vega FM; Sevilla A; Lazo PA
    Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway.
    Kundu N; Brekman A; Kim JY; Xiao G; Gao C; Bargonetti J
    Oncotarget; 2017 Jul; 8(29):47916-47930. PubMed ID: 28615518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage.
    Yan J; Menendez D; Yang XP; Resnick MA; Jetten AM
    J Biol Chem; 2009 Jul; 284(29):19280-9. PubMed ID: 19433585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
    Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
    EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue.
    Shafqat N; Shafqat J; Eissner G; Marschall HU; Tryggvason K; Eriksson U; Gabrielli F; Lardy H; Jörnvall H; Oppermann U
    Cell Mol Life Sci; 2006 May; 63(10):1205-13. PubMed ID: 16685466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2.
    Liu X; Tan Y; Zhang C; Zhang Y; Zhang L; Ren P; Deng H; Luo J; Ke Y; Du X
    EMBO Rep; 2016 Mar; 17(3):349-66. PubMed ID: 26882543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
    Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
    Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells.
    Putri HE; Nutho B; Rungrotmongkol T; Sritularak B; Vinayanuwattikun C; Chanvorachote P
    Phytomedicine; 2021 May; 85():153534. PubMed ID: 33773191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
    Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
    J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.
    Hu B; Gilkes DM; Chen J
    Cancer Res; 2007 Sep; 67(18):8810-7. PubMed ID: 17875722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bre Enhances Osteoblastic Differentiation by Promoting the Mdm2-Mediated Degradation of p53.
    Jin F; Wang Y; Wang X; Wu Y; Wang X; Liu Q; Zhu Y; Liu E; Fan J; Wang Y
    Stem Cells; 2017 Jul; 35(7):1760-1772. PubMed ID: 28436570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.